Understanding retatrutide: why researchers are paying attention Retatrutide represents a significant advancement in GLP-1 receptor agonist research because it activates three metabolic pathways simultaneously rather than one or two
An analysis of studies which involved 49,395 human pregnancies with periconceptional GLP-1 RA exposure found a small but statistically significant association with renal malformations in children, but the researchers said this likely reflects residual confounding by maternal disease severity
"I'm just seething inside just knowing that A, I know they're not taking it for the right reasons, and B, this might not be safe for them." A study published last year became the first to catalogue the risks and benefits of GLP-1s
These tend to appear during dose escalation and fade as the body adapts
Because peptides target different metabolic pathways, their effectiveness may vary depending on a persons health profile, hormone balance, and lifestyle habits